Cargando…

Evaluation of the Efficacy and Safety of Inhaled Epoprostenol and Inhaled Nitric Oxide for Refractory Hypoxemia in Patients With Coronavirus Disease 2019

OBJECTIVES: The objectives of this study were to evaluate the efficacy and safety of inhaled epoprostenol and inhaled nitric oxide in patients with refractory hypoxemia secondary to coronavirus disease 2019. DESIGN: Retrospective single-center study. SETTING: ICUs at a large academic medical center...

Descripción completa

Detalles Bibliográficos
Autores principales:	DeGrado, Jeremy R., Szumita, Paul M., Schuler, Brian R., Dube, Kevin M., Lenox, Jesslyn, Kim, Edy Y., Weinhouse, Gerald L., Massaro, Anthony F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	Observational Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581066/ https://www.ncbi.nlm.nih.gov/pubmed/33134949 http://dx.doi.org/10.1097/CCE.0000000000000259

Ejemplares similares

Effects of Inhaled Epoprostenol and Prone Positioning in Intubated Coronavirus Disease 2019 Patients With Refractory Hypoxemia
por: Li, Jie, et al.
Publicado: (2020)

Nitric oxide versus epoprostenol for refractory hypoxemia in Covid-19
por: Poonam, Pai B. H., et al.
Publicado: (2022)

Evaluation of Hypertriglyceridemia in Critically Ill Patients With Coronavirus Disease 2019 Receiving Propofol
por: Kovacevic, Mary P., et al.
Publicado: (2021)

Comparison of acute hemodynamic effects of inhaled nitric oxide and inhaled epoprostenol in patients with pulmonary hypertension
por: Preston, Ioana R., et al.
Publicado: (2013)

Inhaled pulmonary vasodilators in refractory hypoxemia
por: Wright, Brian J.
Publicado: (2015)

The Incidence of Propofol-Induced Hypertriglyceridemia and Identification of Associated Risk Factors
por: Corrado, Michael J., et al.
Publicado: (2020)

Refractory Cardiogenic Shock from Right Ventricular Infarction Successfully Managed with Inhaled Epoprostenol
por: Held, Natalie, et al.
Publicado: (2017)

Successful use of inhaled epoprostenol as rescue therapy for pediatric ARDS
por: Urich, Alissa, et al.
Publicado: (2020)

Responsiveness of Inhaled Epoprostenol in Respiratory Failure due to COVID-19
por: Sonti, Rajiv, et al.
Publicado: (2020)

HIGH-FLOW NASAL CANULA AND INHALED EPOPROSTENOL RESPONSE IN COVID-19
por: KHURANA, NEHARIKA, et al.
Publicado: (2022)

Respiratory Physiology of Prone Positioning With and Without Inhaled Nitric Oxide Across the Coronavirus Disease 2019 Acute Respiratory Distress Syndrome Severity Spectrum
por: Ziehr, David R., et al.
Publicado: (2021)

Inhaled nitric oxide therapy for severe hypoxemia in hyperinflated mechanically ventilated bronchiolitis patient
por: DonaireGarcia, Alvaro, et al.
Publicado: (2022)

Evaluation of Sedation Outcomes Following Increased Dexmedetomidine Use in the ICU
por: Schuler, Brian R., et al.
Publicado: (2020)

In-vitro and in-vivo comparisons of high versus low concentrations of inhaled epoprostenol to adult intubated patients
por: Li, Jie, et al.
Publicado: (2021)

Inhaled Nitric Oxide as an Adjunct to Thrombolytic Therapy in a Patient with Submassive Pulmonary Embolism and Severe Hypoxemia
por: Toolsie, Omesh, et al.
Publicado: (2019)

Unexpected Interruptions in the Inhaled Epoprostenol Delivery System: Incidence of Adverse Sequelae and Therapeutic Consequences in Critically Ill Patients
por: Block, Jason M., et al.
Publicado: (2021)

Nitric Oxide Inhalation Therapy Attenuates Postoperative Hypoxemia in Obese Patients with Acute Type A Aortic Dissection
por: Zheng, Ping, et al.
Publicado: (2022)

Inhaled epoprostenol therapy for pulmonary hypertension: Improves oxygenation index more consistently in neonates than in older children
por: Brown, Anna T., et al.
Publicado: (2012)

Evaluation of a local ICU sedation guideline on goal-directed administration of sedatives and analgesics
por: DeGrado, Jeremy R, et al.
Publicado: (2011)

Letter to the Editor: “Use of inhaled epoprostenol with high flow nasal oxygen in non-intubated patients with severe COVID-19”
por: Chiles, Joe W., et al.
Publicado: (2022)

Effects of inhaled nitric oxide for postoperative hypoxemia in acute type A aortic dissection: a retrospective observational study
por: Zhang, Hang, et al.
Publicado: (2020)

Retracted: Nitric Oxide Inhalation Therapy Attenuates Postoperative Hypoxemia in Obese Patients with Acute Type A Aortic Dissection
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

The Use of Inhaled Epoprostenol for Acute Respiratory Distress Syndrome Secondary Due To COVID-19: a Case Series
por: Imtiaz, Komal, et al.
Publicado: (2021)

UTILIZING COMBINATION THERAPY WITH INHALED EPOPROSTENOL AND LOOP DIURETICS IN ACUTE HYPOXIC RESPIRATORY FAILURE FROM COVID-19
por: PINO, MARI-ELENA, et al.
Publicado: (2022)

Inhaled and exhaled nitric oxide
por: Thébaud, B., et al.
Publicado: (1999)

Hypoxemia Trajectory of Non-COVID-19 Acute Respiratory Distress Syndrome Patients. An Observational Study Focusing on Hypoxemia Resolver Status
por: Toal, Connor M., et al.
Publicado: (2023)

Inhaled nitric oxide in persistent pulmonary hypertension of the newborn refractory to high-frequency ventilation
por: Al-Alaiyan, Saleh, et al.
Publicado: (1999)

Inhaled nitric oxide: how to deliver it?
por: Troncy, E, et al.
Publicado: (1998)

Successful Weaning From Veno-Venous Extracorporeal Membrane Oxygenation (VV-ECMO) After Initiation of Inhaled Epoprostenol in a Neonate With Refractory Persistent Pulmonary Hypertension of the Newborn (PPHN)
por: Shehzad, Irfan, et al.
Publicado: (2023)

COMPARISON OF HIGHER VERSUS LOWER DOSE STEROID ADMINISTRATION IN PATIENTS WITH COVID-19 AND ACUTE HYPOXEMIC RESPIRATORY FAILURE ON INHALED EPOPROSTENOL
por: RIEGO, MARIA ATHENA, et al.
Publicado: (2022)

A Comparison of Inhaled Epoprostenol in Patients With Acute Respiratory Distress Syndrome and COVID-19-Associated Acute Respiratory Distress Syndrome
por: Robinson, John, et al.
Publicado: (2022)

Inhaled Tranexamic Acid As a Novel Treatment for Pulmonary Hemorrhage in Critically Ill Pediatric Patients: An Observational Study
por: O’Neil, Erika R., et al.
Publicado: (2020)

Inhaled nitric oxide in postpneumonectomy pulmonary edema
por: Keegan, MT, et al.
Publicado: (2003)

Inhaled nitric oxide in infants and children with ARDS
por: Zobel, G, et al.
Publicado: (2000)

Inhaled nitric oxide applications in paediatric practice
por: Bernasconi, A, et al.
Publicado: (2002)

The role of inhaled nitric oxide beyond ARDS
por: Khan, Muhammad Faisal, et al.
Publicado: (2014)

Inhaled nitric oxide, methemoglobinemia, and route of delivery
por: Raut, Monish S., et al.
Publicado: (2017)

Management of refractory hypoxemia
por: Mehta, Chitra, et al.
Publicado: (2016)

Characterization of Nocturnal Neuroactive Medication Use and Related Sleep Documentation in Critically Ill Adults
por: Hamidi, Arzo, et al.
Publicado: (2021)

Prognostic value of oxygen inhalation therapy for simple nocturnal hypoxemia in COPD: a meta-analysis
por: Sun, Ling, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6s9detdf7df7v31pfo31mhogqu